Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kahn

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Hastings Center Report|April 1, 2005
"Ethnic drugs"Jonathan Kahn
Perspectives in Biology and Medicine|November 1, 2003
Getting the numbers right: statistical mischief and racial profiling in heart failure researchJonathan Kahn
Perspectives in Biology and Medicine|August 23, 2011
The two (institutional) cultures: a consideration of structural barriers to interdisciplinarityJonathan Kahn
Nature Genetics|July 2, 2005
Misreading race and genomics after BiDilJonathan Kahn
American Journal of Law & Medicine|December 20, 2017
Pills for Prejudice: Implicit Bias and Technical Fix for RacismJonathan Kahn
The British Journal of Sociology|March 20, 2015
'When are you from?' Time, space, and capital in the molecular reinscription of raceJonathan Kahn
Yale Journal of Health Policy, Law, and Ethics|April 1, 2004
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicineJonathan Kahn
The American Journal of Bioethics : AJOB|September 26, 2006
Race, pharmacogenomics, and marketing: putting BiDil in contextJonathan Kahn
Southern California Interdisciplinary Law Journal|March 6, 2007
From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health careJonathan Kahn
Health Matrix (Cleveland, Ohio : 1991)|December 12, 2022
Diversity's Pandemic DistractionsJonathan Kahn
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Hastings Center Report|April 1, 2005
"Ethnic drugs"Jonathan Kahn
Perspectives in Biology and Medicine|November 1, 2003
Getting the numbers right: statistical mischief and racial profiling in heart failure researchJonathan Kahn
Perspectives in Biology and Medicine|August 23, 2011
The two (institutional) cultures: a consideration of structural barriers to interdisciplinarityJonathan Kahn
Nature Genetics|July 2, 2005
Misreading race and genomics after BiDilJonathan Kahn
American Journal of Law & Medicine|December 20, 2017
Pills for Prejudice: Implicit Bias and Technical Fix for RacismJonathan Kahn
The British Journal of Sociology|March 20, 2015
'When are you from?' Time, space, and capital in the molecular reinscription of raceJonathan Kahn
Yale Journal of Health Policy, Law, and Ethics|April 1, 2004
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicineJonathan Kahn
The American Journal of Bioethics : AJOB|September 26, 2006
Race, pharmacogenomics, and marketing: putting BiDil in contextJonathan Kahn
Southern California Interdisciplinary Law Journal|March 6, 2007
From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health careJonathan Kahn
Health Matrix (Cleveland, Ohio : 1991)|December 12, 2022
Diversity's Pandemic DistractionsJonathan Kahn
Pageof 4